Cartesian Therapeutics, Inc. (RNAC)
7.38
-0.89
(-10.76%)
USD |
NASDAQ |
May 15, 16:00
7.375
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics EPS Diluted (Quarterly) : -1.459 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -0.7591 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Precision BioSciences, Inc. | -0.7486 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.18M |
| Revenue (Quarterly) | 0.078M |
| Total Expenses (Quarterly) | 39.26M |
| Enterprise Value | 110.05M |
| Gross Profit Margin (Quarterly) | -688.5% |
| Profit Margin (Quarterly) | -50.23K% |
| Earnings Yield | -78.56% |
| Normalized Earnings Yield | -51.80 |